Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15032916 | 0.84 | TGFBR1 (0.34) | MMP1MMP8TGFBR1FNTAFNTB | |
| SCHEMBL5038703 | 0.82 | TGFBR1 (0.33) | MMP1MMP8TGFBR1FNTAFNTB | |
| SCHEMBL5050846 | 0.81 | MMP1 (0.38) | MMP1MMP8TGFBR1RXFP1ANPEP | |
| SCHEMBL799428 | 0.77 | TGFBR1 (0.37) | TGFBR1RXFP1MEN1KMT2A | |
| SCHEMBL29518826 | 0.77 | TGFBR1 (0.46) | TGFBR1RXFP1MEN1KMT2A | |
| SCHEMBL22264047 | 0.75 | TSHR (0.42) | MMP1MMP8FNTAFNTBANPEP | |
| SCHEMBL5053966 | 0.75 | LAP3 (0.36) | MMP1MMP8TGFBR1FNTAANPEP | |
| SCHEMBL6440041 | 0.74 | MMP1 (0.31) | MMP1MMP8FNTA | |
| SCHEMBL366427 | 0.74 | CYP2D6 (0.52) | MMP1MMP8TGFBR1RXFP1MEN1 | |
| SCHEMBL10750333 | 0.74 | ANPEP (0.36) | TGFBR1RXFP1ANPEPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BASF SE (DE) | 2026-04-28 | — | — | US | claimed |
| US-20230012924-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2023-01-19 | — | — | US | claimed |
| EP-4077405-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2022-10-26 | — | — | EP | claimed |
| WO-2021126780-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2021-06-24 | — | — | WO | claimed |
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BASF SE (DE) | 2026-04-28 | — | — | US | disclosed |
| WO-2024058248-A1 | DRAW SOLUTE, DRAW SOLUTION, AND METHOD FOR TREATING RAW WATER | 株式会社日本触媒 | 2024-03-21 | — | — | WO | disclosed |
| US-20230416602-A1 | FLUORESCENT POLYMERS AND SOLUTIONS THEREOF FOR SCALE CONTROL IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-12-28 | — | — | US | disclosed |
| EP-4247899-A1 | FLUORESCENT POLYMERS AND SOLUTIONS THEREOF FOR SCALE CONTROL IN AQUEOUS SYSTEMS | Nouryon Chemicals International B.V. (NL) | 2023-09-27 | — | — | EP | disclosed |
| US-20230012924-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2023-01-19 | — | — | US | disclosed |
| US-11542187-B2 | Composition and method for controlling scale in industrial water systems | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-01-03 | — | — | US | disclosed |
| EP-4077405-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2022-10-26 | — | — | EP | disclosed |
| US-20220228054-A1 | FLUORESCENT NAPHTHALIMIDE POLYMERS AND SOLUTIONS THEREOF FOR SCALE CONTROL IN AQUEOUS SYSTEMS | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-07-21 | — | — | US | disclosed |
| US-20160333189-A1 | AQUEOUS COMPOSITE PARTICLE DISPERSION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2016-11-17 | — | — | US | disclosed |
| EP-3093300-A1 | AQUEOUS COMPOSITE PARTICLE DISPERSION | Asahi Kasei Kabushiki Kaisha (JP) | 2016-11-16 | — | — | EP | disclosed |
| EP-1277766-B1 | Polymer compound containing silicon ester moiety and composition therefrom | ROHM & HAAS (US) | 2009-06-24 | — | — | EP | disclosed |
| CN-100342844-C | Polymer water disperser contg. colorant | BASF AG (DE) | 2007-10-17 | — | — | CN | disclosed |
| US-6733884-B2 | ORGANIC POLYMERS WITH ETHYLENICALLY UNSATURATED MONOMERS WITH PENDANT FUNCTIONAL GROUPS, AND A SEMI-TELECHELIC GROUP WITH A SILICON ESTER MOIETY AND A SULFUR ATOM THAT BONDS TO THE ORGANIC POLYMER | ROHM AND HAAS COMPANY | 2004-05-11 | — | — | US | disclosed |
| US-20030017348-A1 | Polymer compound containing silicon ester moiety and composition therefrom | ROHM AND HAAS COMPANY | 2003-01-23 | — | — | US | disclosed |
| EP-1277766-A2 | Polymer compound containing silicon ester moiety and composition therefrom | ROHM AND HAAS COMPANY (US) | 2003-01-22 | — | — | EP | disclosed |
| CN-1348755-A | Polymer water disperser contg. colorant | BASF AG (DE) | 2002-05-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BHMT2, FDFT1, MNAT1 | MMP1 4588/4885MMP8 4456/4885TGFBR1 184/4885 |
| US-20230416602-A1 | FLUORESCENT POLYMERS AND SOLUTIONS THEREOF FOR SCALE CONTROL IN AQUEOUS SYSTEMS | FGB, F10, TFPI | MMP1 655/4885MMP8 1172/4885TGFBR1 4594/4885 |
| US-11542187-B2 | Composition and method for controlling scale in industrial water systems | TP53, PHOSPHO1, PPIP5K2 | MMP1 3778/4885MMP8 4144/4885TGFBR1 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.